Is there an epilepsy belt of high prevalence rate in China?

Wu Li, Zeming Ye, Youfu Li, Ming Luo, Shaojun Li, Hongyan Mi, Zhihua Qiu, Yongjun JiangFrontiers in Neurology 2022 · DOI

TL;DR

Researchers have identified a high-prevalence "epilepsy belt" spanning 12 provincial regions in China, where the prevalence rate (3.32 per 1,000) is nearly double the national average. This belt aligns remarkably with the topographic transition between China’s second and third "steps," suggesting that geographical and environmental factors may influence the disease more than standard socioeconomic metrics.

What Problem Does This Paper Address?

Epilepsy is one of the most common chronic neurological disorders globally, but its distribution is rarely uniform. In the United States, researchers long ago identified a "stroke belt" in the Southeast where mortality from stroke is significantly higher. The authors of this study sought to determine if a similar "epilepsy belt" exists in China.

Given China's vast size, diverse topography, and rapid but uneven economic development, understanding whether certain regions are "hotspots" is critical for public health resource allocation. The study aims to move beyond simple national averages to see if geography itself—rather than just poverty or urbanization—plays a role in epilepsy prevalence.

Methods

The authors conducted a systematic review and meta-analysis of epidemiological data published between 1981 and 2020.

  • Data Synthesis: They analyzed 60 studies covering 29 of China’s 33 provincial regions.
  • Statistical Analysis: To ensure accuracy, they calculated weighted average prevalence rates based on sample sizes.
  • Risk Factor Correlation: They compared the high-prevalence "belt" against other regions using several variables: GDP per capita, urbanization rates, medical insurance coverage, and the percentage of the population under 15.
  • Geographic Mapping: They used color-coded maps to visualize prevalence and risk factors across the country’s three-step topographic ladder.

Datasets

The study relies on a meta-collection of 60 independent epidemiological studies involving over 25 million subjects. Supplemental socioeconomic data was derived from:

  • 2018 China Census data.
  • China Yearbook of Statistics.
  • China Yearbook of Health Statistics.

Key Insights and Ideas

  • The Topographic Transition: The most significant "aha moment" is the alignment of the epilepsy belt with China’s "steps." The belt follows the Daxing’an, Taihang, Wu, and Xuefeng Mountains—the geological divide between the high-altitude western plateaus (second step) and the low-altitude eastern plains (third step).
  • The Socioeconomic Paradox: Conventionally, higher disease rates are associated with lower GDP or poor medical access. However, this study found no significant difference in GDP, urbanization, or medical insurance between the regions inside the belt and those outside. This suggests that the "belt" isn't just a proxy for poverty; something else (environmental or lifestyle-related) is likely at play.
  • Temporal Volatility: The data shows that prevalence in a single region can shift dramatically over decades. For example, in Tibet, recorded prevalence jumped from 2.42 per 1,000 in 1987 to over 23 per 1,000 in 2008 before settling lower in 2009. This highlights the impact of changing diagnostic criteria (WHO vs. ILAE) and sampling methods over time.

Key Results

  • National Average: The average prevalence of epilepsy in China was found to be 1.68 per 1,000.
  • The Belt vs. The Rest: The 12 provincial regions in the "epilepsy belt" showed a prevalence of 3.32 per 1,000, compared to just 1.25 per 1,000 in regions outside the belt ($P < 0.001$).
  • Regional Extremes: Heilongjiang reported the highest prevalence (8.07 per 1,000), while Fujian reported the lowest (0.21 per 1,000).
  • Demographics: The belt covers approximately 34.76% of China’s territory and is home to roughly 44% of its population (approx. 592 million people).

Limitations and Future Work

The authors acknowledge several hurdles:

  • Data Gaps: There was a total lack of survey data for Inner Mongolia, which sits right in the middle of the hypothesized belt.
  • Methodological Heterogeneity: Because the data spans 40 years, the studies used different diagnostic criteria and sampling methods (e.g., door-to-door vs. clue investigation), which can introduce bias.
  • Unexplained Variables: Since standard socioeconomic factors didn't explain the belt, future research needs to look at "finer" variables like local climate (humidity/temperature), specific ethnic dietary habits, or even altitude-related physiological stressors.

In short, while the study confirms the existence of the belt, the why remains a compelling mystery for the next generation of neuro-epidemiologists.

Summary updated

Abstract

An epilepsy belt of high prevalence exists in 12 provincial regions locating along the division between the second step and the third step of China.
BibTeX
@inproceedings{li2022is,
  author = {Wu Li and Zeming Ye and Youfu Li and Ming Luo and Shaojun Li and Hongyan Mi and Zhihua Qiu and Yongjun Jiang},
  title = {{Is there an epilepsy belt of high prevalence rate in China?}},
  booktitle = {Frontiers in Neurology},
  year = {2022},
  doi = {10.3389/fneur.2022.994305},
}
Figure